Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00321360Phase 4Completed
Phase 4, open-label, single-arm trial of propofol in Procedural sedation (PS). Primary endpoints: Minimal Sedation Level (modified Objective Observer's Assessment of Sedation) and Maximal change in oxygen saturation (SpO2). Started May 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00321360.